Cargando…
Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures
BACKGROUND: In recent years, drug combinations have become increasingly popular to improve therapeutic outcomes in various diseases, including difficult to cure cancers such as the brain cancer glioblastoma. Assessing the interaction between drugs over time is critical for predicting drug combinatio...
Autores principales: | Giczewska, Anna, Pastuszak, Krzysztof, Houweling, Megan, Abdul, Kulsoom U, Faaij, Noa, Wedekind, Laurine, Noske, David, Wurdinger, Thomas, Supernat, Anna, Westerman, Bart A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691443/ https://www.ncbi.nlm.nih.gov/pubmed/38047207 http://dx.doi.org/10.1093/noajnl/vdad134 |
Ejemplares similares
-
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies
por: Houweling, Megan, et al.
Publicado: (2023) -
Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020) -
MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors
por: Meel, Michaël H, et al.
Publicado: (2020) -
GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023) -
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
por: van Garderen, Karin A, et al.
Publicado: (2023)